Women with liver problems should not take Gedeon Richter PLC’s uterine fibroid treatment Esmya (ulipristal acetate) because the product may have contributed to the development of some cases of serious liver injury. In addition, liver function tests must be carried out before patients are started on a treatment course with the product.
These are two of the recommendations made by the European Medicines Agency’s pharmacogivilance risk assessment committee (PRAC) at its...




